NCT06604897View on ClinicalTrials.gov

Effectiveness of Entresto (Sacubitril/Valsartan) in Japanese Patients With Hypertension

Active, not recruitingOBSERVATIONAL
Enrollment

1,405

Participants

Timeline

Start Date

January 31, 2023

Primary Completion Date

March 31, 2025

Study Completion Date

March 31, 2025

Conditions
Essential Hypertension
Trial Locations (1)

07936

Novartis, East Hanover

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY

NCT06604897 - Effectiveness of Entresto (Sacubitril/Valsartan) in Japanese Patients With Hypertension | Biotech Hunter | Biotech Hunter